01 November 2005
Sweat production during global heating and during isometric exercise in people with diabetes
Jerrold Petrofsky, Scott Lee, Chris Patterson, Melissa Cole, Brian StewartMed Sci Monit 2005; 11(11): CR515-521 :: ID: 430364
Abstract
Background: While sweat production in response to heat is impaired in peoplewith diabetes, sweat production has not been examined during isometric exercise. Material/Methods: Eightsubjects with type 2 diabetes and 9 control subjects exerted a fatiguing isometric contraction of thehandgrip muscles at a tension of 40% of the maximum voluntary strength (MVC) after exposure to a 32 degC environment for 30 min. compared to 10 controls and 10 subjects with diabetes exposed to a 39 deg Cenvironment. Results: Sweat was impaired to all areas of the body during heat exposure in patients withdiabetes under both environmental conditions. For example, on the chest, the average sweat rates afterexposure to the 32 deg environment was 259.2+/-55.2 nanoliters/min in control subjects and 198.3+/-46.2nanoliters/min for subjects with diabetes. Compared to the 32 deg C environment, control subjects increasedsweat in all 4 areas proportionally more than subjects with diabetes. Sudomotor rhythm was present insweat in control subjects at a rate of repetition of 11 and 50 seconds but almost absent in subjectswith diabetes. During exercise, sweat rates slowly increased from the beginning to the end of the exercise.But the head of the subjects with diabetes showed hypersweating while the other areas showed diminishedsweating compared to control subjects. Conclusions: Thus some of the impairment in sweating may be dueto central mechanisms associated with heat sensitivity or in the hypothalamus and not to the sweat glandsthemselves.
Keywords: Diabetes Mellitus, Type 2 - physiopathology, Exercise, Hot Temperature, Sweat Glands - physiopathology, Sweating
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952